Autosomal dominant neovascular inflammatory vitreoretinopathy with CAPN5 c.731T > C gene mutation; clinical management of a family cohort and review of the literature

References

• O’Keefe G, Hanif AM, Mahajan VB, Jain N. Early onset neovascular inflammatory vitreoretinopathy due to a De Novo CAPN5 mutation: report of a case. Ocul Immunol Inflamm. 2019;27(5):706–8. doi:10.1080/09273948.2019.1582783. Epub 2019 Apr 15. PMID: 30986125; PMCID: PMC7173350.
   PubMed Web of Science ®Google Scholar
• Velez G, Bassuk AG, Schaefer KA, Brooks B, Gakhar L, Mahajan M, Kahn P, Tsang SH, Ferguson PJ, Mahajan VB. A novel de novo CAPN5 mutation in a patient with inflammatory vitreoretinopathy, hearing loss, and developmental delay. Cold Spring Harb Mol Case Stud. 2018 Jun 1;4(3):a002519. doi:10.1101/mcs.a002519. PMID: 29472286; PMCID: PMC5983175.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li H, Zang S, Li F, Chen Y, Zhang X, Song Z, Peng Q, Gu F. Photoreceptor cell-derived CAPN5 regulates retinal pigment epithelium cell proliferation through direct regulation of SLIT2 cleavage. Invest Ophthalmol Visual Sci. 2018 Apr 1;59(5):1810–21. doi:10.1167/iovs.17-22689. PMID: 29610848.
   PubMed Web of Science ®Google Scholar
• Bennett SR, Folk JC, Kimura AE, Russell SR, Stone EM, Raphtis EM. Autosomal dominant neovascular inflammatory vitreoretinopathy. Ophthalmology. 1990 Sep;97(9):1125–35. discussion 1135-6. doi:10.1016/s0161-6420(90)32447-8. PMID: 2234842.
   PubMed Web of Science ®Google Scholar
• Mahajan VB, Skeie JM, Bassuk AG, Fingert JH, Braun TA, Daggett HT, Folk JC, Sheffield VC, Stone EM, Barsh GS. Calpain-5 mutations cause autoimmune uveitis, retinal neovascularization, and photoreceptor degeneration. PLoS Genet. 2012;8(10):e1003001. doi:10.1371/journal.pgen.1003001. Epub 2012 Oct 4. PMID: 23055945; PMCID: PMC3464205.
   PubMed Web of Science ®Google Scholar
• Velez G, Sun YJ, Khan S, Yang J, Herrmann J, Chemudupati T, MacLaren RE, Gakhar L, Wakatsuki S, Bassuk AG, Mahajan VB. Structural insights into the unique activation mechanisms of a non-classical calpain and its disease-causing variants. Cell Rep. 2020 Jan 21;30(3):881–92.e5. doi:10.1016/j.celrep.2019.12.077. PMID: 31968260; PMCID: PMC7001764.
   PubMed Web of Science ®Google Scholar
• Wert KJ, Bassuk AG, Wu WH, Gakhar L, Coglan D, Mahajan M, Wu S, Yang J, Lin CS, Tsang SH, Mahajan VB. CAPN5 mutation in hereditary uveitis: the R243L mutation increases calpain catalytic activity and triggers intraocular inflammation in a mouse model. Hum Mol Genet. 2015 Aug 15;24(16):4584–98. doi:10.1093/hmg/ddv189. Epub 2015 May 20. PMID: 25994508; PMCID: PMC4512628.
   PubMed Web of Science ®Google Scholar
• Velez G, Mahajan VB. Molecular surgery: proteomics of a rare genetic disease gives insight into common causes of blindness. iScience. 2020 Oct 13;23(11):101667. doi:10.1016/j.isci.2020.101667. PMID: 33134897; PMCID: PMC7586135.
   PubMed Web of Science ®Google Scholar
• Bassuk AG, Yeh S, Wu S, Martin DF, Tsang SH, Gakhar L, Mahajan VB, Wen R. Structural modeling of a novel CAPN5 mutation that causes uveitis and neovascular retinal detachment. PLoS One. 2015 Apr 9;10(4):e0122352. doi:10.1371/journal.pone.0122352. PMID: 25856303; PMCID: PMC4391918.
   PubMed Web of Science ®Google Scholar
• Tang PH, Chemudupati T, Wert KJ, Folk JC, Mahajan M, Tsang SH, Bassuk AG, Mahajan VB. Phenotypic variance in calpain-5 retinal degeneration. Am J Ophthalmol Case Rep. 2020 Feb 24;18:100627. doi:10.1016/j.ajoc.2020.100627. PMID: 32274441; PMCID: PMC7132063.
   PubMedGoogle Scholar
• Boyce TM, Whitmore SS, Varzavand K, Russell SR, Sohn EH, Folk JC, Stone EM, Han IC. Long-term outcomes and risk factors for severe vision loss in autosomal dominant neovascular inflammatory vitreoretinopathy (ADNIV). Am J Ophthalmol. 2022 Jan;233:144–52. doi:10.1016/j.ajo.2021.07.015. Epub 2021 Jul 21. PMID: 34302771; PMCID: PMC9177238.
   PubMed Web of Science ®Google Scholar
• Tlucek PS, Folk JC, Sobol WM, Mahajan VB. Surgical management of fibrotic encapsulation of the fluocinolone acetonide implant in CAPN5-associated proliferative vitreoretinopathy. Clin Ophthalmol. 2013;7:1093–8. doi:10.2147/OPTH.S43939. Epub 2013 Jun 10. PMID: 23785231; PMCID: PMC3682853.
   PubMedGoogle Scholar
• Cham A, Bansal M, Banda HK, Kwon Y, Tlucek PS, Bassuk AG, Tsang SH, Sobol WM, Folk JC, Yeh S, et al. Secondary glaucoma in CAPN5-associated neovascular inflammatory vitreoretinopathy. Clin Ophthalmol. 2016 Jun 27;10:1187–97. doi:10.2147/OPTH.S103324. PMID: 27390515; PMCID: PMC4930228.
   PubMedGoogle Scholar
• Tang PH, Kinnick TR, Folk JC, Mahajan M, Bassuk AG, Tsang SH, Mahajan VB. Progression of scotopic single-flash electroretinography in the stages of capn5 vitreoretinopathy. Retin Cases Brief Rep. 2021 Jul 1;15(4):473–8. doi:10.1097/ICB.0000000000000828. PMID: 30300311; PMCID: PMC6453748.
   PubMedGoogle Scholar
• Schaefer KA, Toral MA, Velez G, Cox AJ, Baker SA, Borcherding NC, Colgan DF, Bondada V, Mashburn CB, Yu CG, Geddes JW, Tsang SH, Bassuk AG, Mahajan VB. Calpain-5 expression in the retina localizes to photoreceptor synapses. Invest Ophthalmol Visual Sci. 2016 May 1;57(6):2509–21. doi:10.1167/iovs.15-18680. PMID: 27152965; PMCID: PMC4868102.
   PubMed Web of Science ®Google Scholar
• Randazzo NM MBBCh, BSc(Hons), Shanks ME PhD, Clouston P PhD, FRCPath, MacLaren RE MB ChB, DPhil, FRCOphth. Two novel CAPN5 variants associated with mild and severe autosomal dominant neovascular inflammatory vitreoretinopathy phenotypes. Ocul Immunol Inflamm. 2019;27(5):693–8. doi:10.1080/09273948.2017.1370651. Epub 2017 Oct 17. PMID: 29040051; PMCID: PMC6711405.
   PubMed Web of Science ®Google Scholar
• Mahajan VB, Vallone JG, Lin JH, Mullins RF, Ko AC, Folk JC, Stone EM. T-cell infiltration in autosomal dominant neovascular inflammatory vitreoretinopathy. Mol Vis. 2010 Jun 8;16:1034–40. PMID: 20596252; PMCID: PMC2893052.
   PubMed Web of Science ®Google Scholar
• Velez G, Bassuk AG, Colgan D, Tsang SH, Mahajan VB. Therapeutic drug repositioning using personalized proteomics of liquid biopsies. JCI Insight. 2017 Dec 21;2(24):e97818. doi:10.1172/jci.insight.97818. PMID: 29263305; PMCID: PMC5752263.
   PubMed Web of Science ®Google Scholar
• Amarnani D, Machuca-Parra AI, Wong LL, Marko CK, Stefater JA, Stryjewski TP, Eliott D, Arboleda-Velasquez JF, Kim LA. Effect of methotrexate on an in vitro Patient-derived model of proliferative vitreoretinopathy. Invest Ophthalmol Visual Sci. 2017 Aug 1;58(10):3940–9. doi:10.1167/iovs.16-20912. PMID: 28777835; PMCID: PMC5544356.
   PubMed Web of Science ®Google Scholar
• Chen X, Yang W, Deng X, Ye S, Xiao W. Interleukin-6 promotes proliferative vitreoretinopathy by inducing epithelial-mesenchymal transition via the JAK1/STAT3 signaling pathway. Mol Vis. 2020 Jul 29;26:517–29. PMID: 32818015; PMCID: PMC7406861.
   PubMed Web of Science ®Google Scholar
• Mangla D, Par G, Saggau D, Alliman K, Nielsen J. Management of CAPN5 NIV with intensive combination anti-VEGF and corticosteroid therapy. Invest Ophthalmol Visual Sci. 2019;60(9):3500.
   Web of Science ®Google Scholar
• Vu JT, Wang E, Wu J, Sun YJ, Velez G, Bassuk AG, Lee SH, Mahajan VB. Calpains as mechanistic drivers and therapeutic targets for ocular disease. Trends Mol Med. 2022 Aug;28(8):644–61. doi:10.1016/j.molmed.2022.05.007. Epub 2022 May 29. PMID: 35641420; PMCID: PMC9345745.
   PubMed Web of Science ®Google Scholar
• Velez G, Yang J, Li AS, Tsang SH, Bassuk AG, Mahajan VB. Proteomic insight into the pathogenesis of CAPN5-vitreoretinopathy. Sci Rep. 2019 May 20;9(1):7608. doi:10.1038/s41598-019-44031-7. PMID: 31110225; PMCID: PMC6527583.
   PubMedGoogle Scholar
• DiCarlo JE, Mahajan VB, Tsang SH. Gene therapy and genome surgery in the retina. J Clin Invest. 2018 Jun 1;128(6):2177–88. doi:10.1172/JCI120429. Epub 2018 Jun 1. PMID: 29856367; PMCID: PMC5983345.
   PubMed Web of Science ®Google Scholar
• Wert KJ, Koch SF, Velez G, Hsu CW, Mahajan M, Bassuk AG, Tsang SH, Mahajan VB. CAPN5 genetic inactivation phenotype supports therapeutic inhibition trials. Hum Mutat. 2019 Dec;40(12):2377–92. doi:10.1002/humu.23894. Epub 2019 Aug 26. PMID: 31403230; PMCID: PMC7493429.
   PubMed Web of Science ®Google Scholar
• Wert KJ, Skeie JM, Bassuk AG, Olivier AK, Tsang SH, Mahajan VB. Functional validation of a human CAPN5 exome variant by lentiviral transduction into mouse retina. Hum Mol Genet. 2014 May 15;23(10):2665–77. doi:10.1093/hmg/ddt661. Epub 2013 Dec 30. PMID: 24381307; PMCID: PMC3990166.
   PubMed Web of Science ®Google Scholar